2.3. Cell Viability Tetrazolium Reduction Assay (MTS)

KK Kamil A. Kobak
PF Paweł Franczuk
JS Justyna Schubert
MD Magdalena Dzięgała
MK Monika Kasztura
MT Michał Tkaczyszyn
MD Marcin Drozd
AK Aneta Kosiorek
LK Liliana Kiczak
JB Jacek Bania
PP Piotr Ponikowski
EJ Ewa A. Jankowska
request Request a Protocol
ask Ask a question
Favorite

MTS assays were performed, according to the manufacturer’s protocol (CellTiter 96® AQueous One Solution Cell Proliferation Assay; Promega Corporation, Madison, WI, USA). Briefly, hCM or hCF cells were seeded into each well of 96-well plates and were treated for 48 h with patients’ sera or PBS (control), as described above. A total of 20 µL CellTiter 96® AQueous One Solution reagent was added to each well, and the absorbance at 490 nm was measured after 2 h incubation in 37 °C (KCjunior™; BioTek Instruments, Inc., Winooski, VT, USA). The viability of the untreated cells was treated as 100%.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A